IP Library › Patent Application 15876899
Patent Application
App. No. 15/876,899

Generation of Inner Ear Cells

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/876,899
Abstract

Methods for generating cells of the inner ear, e.g., hair cells and supporting cells, from stem cells, e.g., mesenchymal stem cells, are provided, as well as compositions including the inner ear cells. Methods for the therapeutic use of the inner ear cells for the treatment of hearing loss are also described.

Claims (13)

1 . A method of generating a differentiated inner ear cell, the method comprising:

contacting a progenitor cell that expresses one or more of nestin, sox2, musashih, or Pax2, with a gamma secretase inhibitor in an amount and for a time sufficient to induce the progenitor cell to express one or more of atonal homolog 1 (Atoh1), jagged 2, p27 Kip , myosin VIIa, or espin, thereby producing a differentiated inner ear cell.

2 . The method of claim 1 , wherein the progenitor cell is obtained by a method comprising:

providing a mesenchymal_stem cell; and

culturing the mesenchymal stem cell under conditions sufficient to induce the stem cell to differentiate into the progenitor cell.

3 . The method of claim 2 , wherein the mesenchymal stem cell is obtained from a subject who has sensorineural hair cell loss.

4 . The method of claim 2 , wherein culturing the mesenchymal stem cell comprises maintaining the stem cell in medium comprising an epidermal growth factor, a fibroblast growth factor, or an insulin-like growth factor.

5 . The method of claim 2 , wherein culturing the mesenchymal stem cell comprises maintaining the stem cell in medium comprising neurotrophin-3 or a brain derived neurotrophic factor.

6 . The method of claim 1 , wherein the gamma secretase inhibitor is an aryl sulfonamide, a dibenzazepine, a benzodiazepine, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT), L-685,458, or MK0752.

7 . The method of claim 1 , wherein the differentiated cell is an inner ear auditory hair cell.

8 . The method of claim 7 , wherein the inner ear auditory hair cell expresses Atoh1, myosin7a, epsin and p 27 Kip.

9 . The method of claim 1 , wherein the progenitor cell expresses Sox2 and Pax2.

10 . The method of claim 2 , wherein the progenitor cell expresses Sox2 and Pax2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2018
From: EDGE, ALBERT
To: MASSACHUSETTS EYE & EAR INFIRMARY
Reel/Frame 044811/0799 →